Eltrombopag Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets & Oral Powder for Oral Suspension
Available Strengths: Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet
Reference Brands: Promacta,Revolade
Category:
Anemia
Eltrombopag is an oral thrombopoietin receptor agonist used to treat chronic ITP, severe aplastic anemia, and hepatitis C-related thrombocytopenia. Marketed as Promacta and Revolade, it boosts platelet production and reduces transfusion needs. Ideal for pharma B2B sourcing.
Eltrombopag is available in Oral Tablets & Oral Powder for Oral Suspension
and strengths such as Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Eltrombopag is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Eltrombopag can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and hepatitis C-associated thrombocytopenia. Marketed globally as Promacta (US) and Revolade (EU/Worldwide), it stimulates platelet production and reduces bleeding risk. Available in GMP-certified oral tablets and pediatric suspension, Eltrombopag is a high-demand product in hematology. Ideal for pharmaceutical wholesalers, importers, and B2B buyers seeking reliable sourcing of specialty medicines. We offer bulk supply, export support, and regulatory documentation. Partner with us for competitive pricing and global delivery of Eltrombopag. Contact us today to secure your supply of Eltrombopag for pharma B2B needs.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing